Princess Dina Mired of Jordan, director general of the King Hussein Cancer Foundation, and president of the Union for International Cancer Control (UICC), Wednesday visited Hamad Medical Corporation’s (HMC) National Center for Cancer Care and Research (NCCCR) and Hamad General Hospital (HGH) as part of her official visit to Qatar.
Accompanied by Dr Hadi Mohamed Abu Rasheed, supervisor of Health Education at the Qatar Cancer Society, Princess Dina was welcomed to NCCCR by Professor Alex Knuth, medical director and CEO; Dr Al Hareth al-Khater, deputy medical director; Dr Ussama al-Homsi, chairman of Medical Oncology and Hematology; Catherine Gillespie, executive director of Nursing and director of Qatar’s National Cancer Programme, and Dr Ahmad al-Mulla, head of the HMC Tobacco Control Center.
After a brief presentation on the Qatar National Cancer Strategy and the role of NCCCR in improving cancer care in Qatar, the delegation visited some of the hospital’s specialist units.
The group toured the Radiation Oncology Department where the princess viewed the Positron Emission Tomography-Computed Tomography (PEC/CT) facility and the Robotic Radiosurgery System (Cyberknife).
Professor Knuth said: “We are delighted to welcome Princess Dina to NCCCR. This is a very special visit as it embodies the strong and trusted relationship between Jordan and Qatar and symbolises the importance of mutual cooperation between the King Hussein Cancer Foundation and NCCCR.”
Princess Dina later visited HGH where she was welcomed by a small group of the hospital’s executive leadership and senior consultants, including Aidan Kehoe, CEO; Dr Mohamed Salem Jabor al-Hassan, chairman of Surgical Oncology; Dr Ahmed Zarour, head of Acute Care Surgery Section; Dr Moustafa Khalil, director of Operating Theaters and chairman of the Head and Neck Tumor Board, and Dr Aftab Mohamed Azad, deputy chairman, Corporate Emergency Department.
Princess Dina also visited the new operating theater facility.
“As the busiest hospital in HMC’s network, HGH plays a key role in the delivery of specialist healthcare services to Qatar’s population, including the delivery of specialist cancer surgical procedures. Our new operating theater facility opened in 2016 and has significantly advanced the quality of care we provide to cancer patients who require surgical interventions,” stated Dr al-Hassan.
The visit of Princess Dina showcased the work of UICC and its impact in helping to reduce the global burden of cancer.
The occasion was also used to discuss the World Cancer Congress and the World Cancer Leaders' Summit, which will be held in Oman in 2020.
Princess Dina Mired of Jordan during her tour of Hamad General Hospital.
